XRAY
Undervalued by 53% based on the discounted cash flow analysis.
Market cap | $3.88 Billion |
---|---|
Enterprise Value | $5.91 Billion |
Dividend Yield | $0.64 (3.27700972862263%) |
Earnings per Share | $-0.62 |
Beta | 1.03 |
Outstanding Shares | 201,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -9.5 |
---|---|
PEG | -11.09 |
Price to Sales | 1.03 |
Price to Book Ratio | 1.63 |
Enterprise Value to Revenue | 1.51 |
Enterprise Value to EBIT | 48.41 |
Enterprise Value to Net Income | -15 |
Total Debt to Enterprise | 0.39 |
Debt to Equity | 0.93 |
No data
No data